Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia

被引:298
作者
Attie, AD
Krauss, RM
Gray-Keller, MP
Brownlie, A
Miyazaki, M
Kastelein, JJ
Lusis, AJ
Stalenhoef, AFH
Stoehr, JP
Hayden, MR
Ntambi, JM
机构
[1] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA
[2] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA
[3] Xenon Genet Inc, Burnaby, BC, Canada
[4] Acad Med Ctr, Amsterdam, Netherlands
[5] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA
[6] Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[7] Univ British Columbia, Ctr Mol, Vancouver, BC V5Z 1M9, Canada
[8] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada
[9] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA
关键词
metabolic syndrome; hyperlipidemia; monounsaturated farty acids;
D O I
10.1194/jlr.M200189-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stearoyl-CoA desaturase (SCD) is expressed at high levels in several human tissues and is required for the biosynthesis of oleate (18:1) and palmitoleate (16:1). These monounsaturated fatty acids are the major components of phospholipids, triglycerides, wax esters, and cholesterol esters. Mice with a targeted disruption of the SCD I gene have very low levels of VLDL and impaired triglyceride and cholesterol ester biosynthesis. In the HYPLIP mouse, a model of hyperlipidemia, there was a 4-fold increase in hepatic SCD activity, a 1.8-fold increase in the desaturation index, and a 2-fold increase in plasma triglycerides. We used the plasma ratio of 18:1/18:0 (the "desaturation index") as an in vivo measure of SCD activity in human subjects. In human subjects with triglycerides ranging from 0.3 to 20 mM, the desaturation ratio accounted for one-third of the variance in plasma triglyceride levels. A 2-fold increase in the desaturation index was associated with a 4-fold increase in plasma triglycerides. In human subjects exposed to a high carbohydrate diet, the desaturation index explained 44% of the variance in triglycerides. We propose that many of the factors that influence plasma triglyceride levels do so by converging upon the regulation of SCD activity.
引用
收藏
页码:1899 / 1907
页数:9
相关论文
共 44 条
  • [1] ANGELIN B, 1978, J LIPID RES, V19, P1004
  • [2] BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
  • [3] Positional cloning of the combined hyperlipidemia gene Hyplip1
    Bodnar, JS
    Chatterjee, A
    Castellani, LW
    Ross, DA
    Ohmen, J
    Cavalcoli, J
    Wu, CY
    Dains, KM
    Catanese, J
    Chu, M
    Sheth, SS
    Charugundla, K
    Demant, P
    West, DB
    de Jong, P
    Lusis, AJ
    [J]. NATURE GENETICS, 2002, 30 (01) : 110 - 116
  • [4] DIETARY CARBOHYDRATE INDUCES LIPOGENESIS AND VERY-LOW-DENSITY LIPOPROTEIN SYNTHESIS
    BOOGAERTS, JR
    MALONEMCNEAL, M
    ARCHAMBAULTSCHEXNAYDER, J
    DAVIS, RA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (01): : E77 - E83
  • [5] Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
    Brooks-Wilson, A
    Marcil, M
    Clee, SM
    Zhang, LH
    Roomp, K
    van Dam, M
    Yu, L
    Brewer, C
    Collins, JA
    Molhuizen, HOF
    Loubser, O
    Ouelette, BFF
    Fichter, K
    Ashbourne-Excoffon, KJD
    Sensen, CW
    Scherer, S
    Mott, S
    Denis, M
    Martindale, D
    Frohlich, J
    Morgan, K
    Koop, B
    Pimstone, S
    Kastelein, JJP
    Genest, J
    Hayden, MR
    [J]. NATURE GENETICS, 1999, 22 (04) : 336 - 345
  • [6] The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
    Brown, MS
    Goldstein, JL
    [J]. CELL, 1997, 89 (03) : 331 - 340
  • [7] Mapping a gene for combined hyperlipidaemia in a mutant mouse strain
    Castellani, LW
    Weinreb, A
    Bodnar, J
    Goto, AM
    Doolittle, M
    Mehrabian, M
    Demant, P
    Lusis, AJ
    [J]. NATURE GENETICS, 1998, 18 (04) : 374 - 377
  • [8] Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity
    Diraison, F
    Dusserre, E
    Vidal, H
    Sothier, M
    Beylot, M
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 282 (01): : E46 - E51
  • [9] DIXON JL, 1993, J LIPID RES, V34, P167
  • [10] Duane WC, 2000, J LIPID RES, V41, P1384